Objective To investigate whether low ganciclovir serum levels in patients on maintenance
oral ganciclovir therapy are associated with recurrence of CMV retinitis. Methods A …

Objectives: To compare the safety and efficacy of oral ganciclovir with intravenous
ganciclovir for the maintenance therapy of cytomegalovirus (CMV) retinitis in AIDS patients …

Objectives: To determine whether recurrence of polymerase chain reaction (PCR) viraemia
during maintenance ganciclovir for cytomegalovirus (CMV) retinitis correlates with (i) CMV …

Background: The oral formulation of ganciclovir is approved at a dose of 3.0 g/day for
maintenance treatment of cytomegalovirus (CMV) retinitis following an initial induction …

Objective: To determine the relative effectiveness of an oral formulation compared to a
standard intravenous regimen of ganciclovir in preventing the progression of …

Background Cytomegalovirus retinitis, a sight-threatening infection associated with the
acquired immunodeficiency syndrome (AIDS), currently requires lifelong intravenous …

We report the first randomized prospective comparative study of long‐term maintenance
ganciclovir (9‐[2‐hydroxy‐1‐(hydroxymethyl) ethoxymethyl] guanine, BW759U, DHPG) …

Abstract A phase I/II study evaluated the pharmacokinetics, tolerability, and antiviral activity
of oral ganciclovir in persons infected with human immunodeficiency virus (HIV). Oral …

Objectives: Despite life-long maintenance therapy, cytomegalovirus (CMV) retinitis
frequently progresses in patients with AIDS. Virological markers that could clarify …

Oral ganciclovir has recently been approved for use in long-term maintenance therapy in the
treatment of cytomegalovirus (CMV) retinitis in immunocompromised patients. Although oral …